Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
SUSAN C. TAYLOR, MD, FAAD, ASSUMES PRESIDENCY OF THE AMERICAN ACADEMY OF DERMATOLOGY
-
Now is the Time to Process W2 and W3 Corrections with ezW2Correction to Avoid Penalties
-
Black Cowboys Take Center Stage: 8 Seconds Rodeo Expands for Its Biggest Year Yet!
-
Nayax Announces Preliminary Results of Notes and Warrants Offering in Israel to Classified Investors
-
IMFINZI® (durvalumab)-based regimen demonstrated statistically significant and clinically meaningful improvement in event-free survival in resectable early-stage gastric and gastroesophageal junction
-
TRANSFORM YOUR SKIN HEALTH: DIET AND LIFESTYLE TAKE CENTER STAGE AT 2025 AAD ANNUAL MEETING
-
Nusano’s Jzaneen Lalani Named to Top 50 Women Leaders in Healthcare Technology List
-
MSC Income Fund Announces Second Quarter Regular Quarterly Dividend and Supplemental Quarterly Dividend
-
Capstone Copper Announces Inclusion in the S&P/ASX 200 Index
-
TTNE: World Sauna Award "SAUNA37” 2025 Launched on March 7th
-
Apollo Files N.I. 43-101 Technical Report for the Cinco de Mayo Project, Chihuahua State, Mexico
-
New Data to be Presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting Further Strengthens Evidence Supporting the Clinical Value of Castle Biosciences' Dermatology Portfolio
-
The Cannabist Company Achieves Approximately 70% Support for Previously Announced Agreement to Extend the Maturity Date of its Senior Secured Notes
-
I-Mab Announces Accelerated Givastomig Phase 1b Study Progress
-
CBE Cancels In-Person Parent Visits Due to Strike
-
Advantage Solutions Reports Fourth Quarter and 2024 Results: Transformation Initiatives Continue to Strengthen the Company
-
Baltic Horizon Fund to sell Meraki Business Home in Vilnius, Lithuania
-
Lithium Carbonate Futures Now Live for Trading on Abaxx Exchange
-
Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Unresectable or Advanced Hepatocellul
-
Mainstreet Announces 90% Shareholder Participation at Annual General Meeting
-
Modiv Industrial Increases AFFO and Retires Preferred Shares
-
Bybit Web3 Expands bbSOL Utility with Jito Restaking for Enhanced Rewards and Liquidity
-
Genesco Inc. Reports Fiscal 2025 Fourth Quarter and Full Year Results
-
NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
-
February Recap: 15 Top Health Press Releases
-
Resolution Life Announces $9.7 billion Strategic Reinsurance Agreement with Protective Life
-
Leading Credit Card Processing Companies and ISO Programs for 2025
-
TopSEOs.com Reveals Leading SEO Companies for 2025
-
New Google Review Management Service Boosts Reputation
-
Man Group PLC : Form 8.3 - Dalata Hotel Group plc
-
Cequire Capital Backs Wyscale with 1 Million Dollars Investment to Drive Web3 Innovation
-
Global leaders heading to Bridgetown for critical discussions on energy, climate and sustainable development
-
Auction result of Treasury Bonds - RIKB 26 1015 - RIKB 38 0215
-
February Recap: 10 Top Finance Press Releases
-
BFCM Communiqué de mise à disposition des Final Terms de l’émission séries 579 tranche 8
-
Man Group PLC : Form 8.3 - Dowlais Group plc
-
Oclean: Women vs. Men - Oral Hygiene Research Report
-
Algonquin Power & Utilities Corp. Announces 2024 Fourth Quarter and Full Year Financial Results
-
Algonquin Power & Utilities Corp. Declares First Quarter 2025 Common Share Dividend of U.S.$0.0650 (C$0.0934), and Declares First Quarter 2025 Preferred Share Dividends
-
AAD 2025: Almirall presents early-stage pipeline progress and real-world evidence on demonstrating AK treatment success and patient satisfaction with Tirbanibulin
-
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings Inc
-
KuCoin Launches KCS Loyalty Level Program: Redefine the KCS Ecosystem and Unlock New Privileges
-
February Recap: 15 Top Consumer Press Releases
-
Forvia: Availability of the 2024 Universal Registration Document
-
Ryde Strengthens Direct Engagement with Driver-Partners Through "Ask My CEO a Question" Initiative
-
BFCM Communiqué de mise à disposition des Final Terms de l’émission série 584 tranche 1
-
inTEST Corporation Renews Stock Repurchase Plan
-
Havila Kystruten AS: Trading Update for February 2025
-
inTEST Reports Fourth Quarter 2024 Revenue Grew 31% and Operating Income Increased 87% Year-over-Year
-
Exclusive Network: Press Release Dated 7 March 2025
